Actavis Announces Proposed Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan
Actavis Announces Proposed Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan PR Newswire DUBLIN, March 2, 2015 DUBLIN , March 2, 2015 /PRNewswire/ — Actavis plc (NYSE: ACT) today announced that it is commencing an offering of senior unsecured notes in multiple tranches in a registered public offering to be issued by its indirect subsidiary, Actavis Funding SCS, and guaranteed by certain of its other subsidiaries, subject to market and other conditions (the “Notes”). Logo – http://photos.prnewswire.com/prnh/20130124/NY47381LOGO Actavis plc intends to use the net proceeds from the offering of the Notes, together with the proceeds from its offerings of its Ordinary Shares and 5.500% Mandatory Convertible Preferred Shares, Series A (together with the offering of Ordinary Shares, the “Equity Offerings”), and additional debt financing, including borrowings under unsecured term loan facilities and an unsecured cash bridge loan facility, to finance the cash portion of the merger consideration for its previously announced acquisition (the “Allergan Acquisition”) of Allergan, Inc. (“Allergan”) and to pay related fees and expenses. […]